Abstract:Significance: Nuclear factor kappa B (NF-κB) is a master regulator of the inflammatory response and represents a key regulatory node in the complex inflammatory signaling network. In addition, selective NF-κB transcriptional activity on specific target genes occurs through the control of redox-sensitive NF-κB interactions. Recent Advances: The selective NF-κB response is mediated by redox-modulated NF-κB complexes with ribosomal protein S3 (RPS3), Pirin (PIR). cAMP response element-binding (CREB)-binding protein (CBP)/p300, peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α), activator protein-1 (AP-1), signal transducer and activator of transcription 3 (STAT3), early growth response protein 1 (EGR-1), and SP-1. NF-κB is cooperatively coactivated with AP-1, STAT3, EGR-1, and SP-1 during the inflammatory process, whereas NF-κB complexes with CBP/p300 and PGC-1α regulate the expression of antioxidant genes. PGC-1α may act as selective repressor of phospho-p65 toward interleukin-6 (IL-6) in acute inflammation. p65 and nuclear factor erythroid 2-related factor 2 (NRF2) compete for binding to coactivator CBP/p300 playing opposite roles in the regulation of inflammatory genes. S-nitrosylation or tyrosine nitration favors the recruitment of specific NF-κB subunits to κB sites. Critical Issues: NF-κB is a redox-sensitive transcription factor that forms specific signaling complexes to regulate selectively the expression of target genes in acute inflammation. Protein-protein interactions with coregulatory proteins, other transcription factors, and chromatin-remodeling proteins provide transcriptional specificity to NF-κB. Furthermore, different NF-κB subunits may form distinct redox-sensitive homo- and heterodimers with distinct affinities for κB sites. Future Directions: Further research is required to elucidate the whole NF-κB interactome to fully characterize the complex NF-κB signaling network in redox signaling, inflammation, and cancer.

Progress in Research in Nuclear Factor-_κB and Coronary Heart Disease

Research Progress on Relationship Between Transcription Factor Sp1 and Tumor

Relationship Between Nuclear Factor-κB and Coronary Heart Disease

The Research Advance of Nuclear Hormone Receptors in Immune Regulation

Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure

Expression of Nuclear Factor-Κb in the Diabetic Renal Tissue and Intervened Therapy

Nf-Kappa B and Its Regulation on the Immune System

NF‐κB signaling in inflammation and cancer

The role of NF-κB in diabetic cardiomyopathy

Potential Role of Nuclear Factor κB in Diabetic Cardiomyopathy

Post-translational Modifications of IB: The State of the Art

Nuclear factor-kappa B and its role in inflammatory lung disease

The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases

Regulation of nuclear factor-κB in autoimmunity

Relationship between nuclear factor-κB and pathogenesy of bronchial asthma and its clinical significance

The role of NF-κB in myocardial ischemia/reperfusion injury.

Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System

Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches

The correlation between nuclear factor kappa B expressed in peripheral blood mononuclear cells and the characteristics of coronary atherosclerosis plaque in patients with acute coronary syndrome

Nuclear Factor Kappa B Signaling Complexes in Acute Inflammation

Post-translational Modifications of IκBα: The State of the Art